You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
貝康醫療-B(02170.HK)中期收入增加45.8%至1.25億元
格隆匯 08-29 23:17

格隆匯8月29日丨貝康醫療-B(02170.HK)公吿,公司收入增加45.8%至截至2024年6月30日止六個月的人民幣124.7百萬元。該增加主要由於(i)新加坡BMX收購事項後將新加坡BMX的財務表現納入公司的全球銷售業績;及(ii)公司五大實驗室場景下的核心產品的銷售保持了穩健增長。PGT試劑盒、胚胎培養箱及超低温存儲產品的銷量均實現預期增速。

集團的毛利增加72.3%至截至2024年6月30日止六個月的人民幣57.9百萬元。集團的整體毛利率從截至2023年6月30日止六個月的39.2%增加至截至2024年6月30日止六個月的46.4%,主要是因為新加坡BMX收購事項使得產品組合優化提高了整體毛利率。

截至2024年6月30日,公司在中國註冊了118項專利、125個商標、57個軟件版權及16個域名。公司另在香港註冊了四個商標,在美國註冊了一個商標,在日本註冊一個商標。截至同日,公司在中國提交了65項專利申請。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account